1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Diabetes and other endocrinal, nutritional and metabolic conditions
  5. Diabetes

MiniMed 640G system with SmartGuard for managing blood glucose levels in people with type 1 diabetes

Medtech innovation briefing [MIB51] Published: 12 February 2016

  • Overview
  • Summary
  • Introduction
  • Technology overview
  • Evidence review
  • Relevance to NICE guidance programmes
  • References
  • Appendix
  • Search strategy and evidence selection
  • About this briefing
Download (PDF)

Advice

  • Next

Relevance to NICE guidance programmes

Relevance to NICE guidance programmes

NICE has issued the following guidance:

  • Integrated sensor-augmented pump therapy systems for managing blood glucose levels in type 1 diabetes (the MiniMed Paradigm Veo system and the Vibe and G4 PLATINUM CGM system) (2016) NICE diagnostics guidance DG21

  • Type 1 diabetes in adults (2015) NICE guideline NG17

  • Diabetes (type 1 and type 2) in children and young people (2015) NICE guideline NG18

  • Diabetes in pregnancy (2015) NICE guideline NG3

  • Continuous subcutaneous insulin infusion for the treatment of diabetes mellitus (2008) NICE technology appraisal guidance TA151


  • Next